Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2006
06/08/2006CA2738383A1 Bicyclic amides as kinase inhibitors
06/08/2006CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
06/08/2006CA2589740A1 Cyclic iminocarbamates and use thereof
06/08/2006CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof
06/08/2006CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases
06/07/2006EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents.
06/07/2006EP1666479A1 Crystal of heterocyclic compound
06/07/2006EP1666472A1 Phenylacetic acid derivative, process for producing the same, and use
06/07/2006EP1666067A1 Drug containing chymase inhibitor as the active ingredient
06/07/2006EP1664043A2 Compositions useful as inhibitors of protein kinases
06/07/2006EP1664039A1 1,3-benzoxazolyl derivatives as kinase-inhibitors
06/07/2006EP1664038A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved i in vivo /i efficacy
06/07/2006EP1664036A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
06/07/2006EP1664035A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
06/07/2006EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
06/07/2006EP1664030A1 Quinazoline derivatives
06/07/2006EP1664029A1 Quinazoline derivatives as antitumor agents
06/07/2006EP1664026A1 Mitotic kinesin inhibitors
06/07/2006EP1664025A1 Pyrrol derivatives with antibacterial activity
06/07/2006EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
06/07/2006EP1664016A2 Therapeutic agents useful for treating pain
06/07/2006EP1664010A1 Sulfonamides antagonising n-type calcium channels
06/07/2006EP1664002A1 Organic compounds
06/07/2006EP1664001A2 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same
06/07/2006EP1664000A1 Isoxazoles as peptide deformylase inhibitors
06/07/2006EP1663999A2 Inhibitors of phosphodiesterase type-iv
06/07/2006EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels
06/07/2006EP1663975A1 Novel gamma secretase inhibitors
06/07/2006EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
06/07/2006EP1663966A1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
06/07/2006EP1663965A2 Thrombin receptor antagonists
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1663254A2 Anti-inflamatory phosphonate conjugates
06/07/2006EP1663237A2 Fused ring heterocycles as potassium channel modulators
06/07/2006EP1663235A1 Capped pyrazinoylguanidine sodium channel blockers
06/07/2006EP1663228A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
06/07/2006EP1663223A2 Thalidomide analogs as tnf-alpha modulators
06/07/2006EP1663213A1 Substituted oxadiazolidinediones as pai-1 inhibitors
06/07/2006EP1663210A1 N3 alkylated benzimidazole derivatives as mek inhibitors
06/07/2006EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis
06/07/2006EP1599878B1 Optical recording materials having high storage density
06/07/2006EP1585725A4 Compounds which mimic the chemical and biological properties of discodermolide
06/07/2006EP1427723B1 Tetrahydropyran derivatives and their use as therapeutic agents
06/07/2006EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors
06/07/2006EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
06/07/2006EP1292593B1 2-(3,5-disubstituted-4-pyridyl)-4-(thienyl, thiazolyl or arylphenyl)-1,3-oxazoline compounds
06/07/2006EP1259489B1 Aryl fused azapolycyclic compounds
06/07/2006EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents
06/07/2006CN1784416A 9-ketospinosyn derivatives
06/07/2006CN1784399A 3-carbonylaminothiophenes and their use as fungicides
06/07/2006CN1784396A P38 inhibitors and methods of use thereof
06/07/2006CN1784393A Chemical compounds
06/07/2006CN1784391A Quinazolines useful as modulators of ion channels
06/07/2006CN1784383A N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
06/07/2006CN1784231A 1-amino 1H-imidazoquinolines
06/07/2006CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems
06/07/2006CN1781915A Method for producing an oxazolylethanol derivative
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/06/2006US7057048 Androgen receptor antagonists
06/06/2006US7057047 reacting 2-diaminopyridine with malic/sulfuric acid to form 2-amino-7-hydroxy-1,8-naphthyridine sulfuric acid salt, reacting in solvent to form phthalimidyl naphthyridine, chlorinating, reducing to hydroxyindolinone, then reacting with 5-methyl-2-oxo-hexyltriphenylphosphonium halide to form racemate
06/06/2006US7057046 Lactam glycogen phosphorylase inhibitors and method of use
06/06/2006US7057040 Substituted aryl alkenoic acid heterocyclic amides
06/06/2006US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I
06/06/2006US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
06/06/2006US7057037 P-bis(4-(oxo)-4H-3,1-benzazin-2-yl)benzene having a melt beginning temperature and/or a weight loss beginning temperature obtained under a specified condition adjusted within a specified range; heat resistance; transparent
06/06/2006US7056941 for efficient control of animal pests from the class of insects, arachnids and nematodes, for controlling broad spectrum of phytopathogenic fungi, in particular from the class of the Ascomycetes, Deuteromycetes, Phycomycetes and Basidiomycetes
06/06/2006US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists
06/06/2006US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides
06/06/2006US7056923 Anticoagulants
06/06/2006US7056918 Benzimidazole anti-inflammatory compounds
06/06/2006US7056915 Compounds useful as reversible inhibitors of cysteine proteases
06/06/2006US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments
06/06/2006US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria
06/06/2006US7056348 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair)
06/06/2006CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor
06/06/2006CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists
06/06/2006CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
06/06/2006CA2136903C Acetic acid derivatives
06/01/2006WO2006058201A2 Heterocyclic and bicyclic compounds, compositions and methods
06/01/2006WO2006058012A2 Gonadotropin releasing hormone receptor antagonists
06/01/2006WO2006057983A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
06/01/2006WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors
06/01/2006WO2006057460A1 Nitrogen-containing fused ring compound and use thereof
06/01/2006WO2006057448A1 Arylalkanoic acid derivative
06/01/2006WO2006057113A1 Cyanine compound, optical recording material utilizing the compound, and optical recording medium
06/01/2006WO2006056877A2 Diazepine oxazolidinones as antibacterial agents
06/01/2006WO2006056850A2 Chroman compounds
06/01/2006WO2006056427A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
06/01/2006WO2006036015A3 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors
06/01/2006WO2006033844A3 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
06/01/2006WO2006031929A3 Thiazolopyridine kinase inhibitors
06/01/2006WO2006028957A8 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
06/01/2006WO2005061467A3 Piperazine derivatives as bradykinin antagonists
06/01/2006WO2005040139A8 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors
06/01/2006US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant
06/01/2006US20060116408 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents; methyl 4-(5-chloro-3-methylbenzo[b]thiophene-2-sulfonylamino)-3-methanesulfonylbenzoate
06/01/2006US20060116407 Amide derivatives
06/01/2006US20060116405 Indol derivatives and their use as 5-ht ligands
06/01/2006US20060116401 Antibacterial compounds
06/01/2006US20060116400 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents